Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Other
Ratios

NewAmsterdam Pharma (NAMS) Other Gross PP&E Adjustments (2022 - 2025)

NewAmsterdam Pharma's Other Gross PP&E Adjustments history spans 4 years, with the latest figure at -$1.9 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 40.6% year-over-year to -$1.9 million; the TTM value through Dec 2025 reached -$1.9 million, up 40.6%, while the annual FY2025 figure was -$1.9 million, 40.6% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$1.9 million at NewAmsterdam Pharma, up from -$2.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$1.7 million in Q1 2024 and bottomed at -$3.6 million in Q1 2025.
  • The 4-year median for Other Gross PP&E Adjustments is -$2.7 million (2025), against an average of -$2.6 million.
  • The largest YoY upside for Other Gross PP&E Adjustments was 40.6% in 2025 against a maximum downside of 111.68% in 2025.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at -$3.1 million in 2022, then surged by 31.53% to -$2.1 million in 2023, then tumbled by 52.97% to -$3.2 million in 2024, then skyrocketed by 40.6% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for NAMS's Other Gross PP&E Adjustments are -$1.9 million (Q4 2025), -$2.3 million (Q3 2025), and -$3.0 million (Q2 2025).